ArticleJournal of translational medicine2008

NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.

Anna Bratasz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.